Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-007996

General Counsel and Secretary sold 29,971 shares at $29.07 ($871,257)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Lara General Counsel and Secretary 2023-03-09 Sale −29,971 $29.07 $871,257 0 D
Open-market sales · 29,971 sh · avg $29.07 · $871,257
Loading xslF345X03/doc4.xml…